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ABSTRACT 
 
This study focuses on the possible ways to improve healthcare services around the 
world, which increase the life expectancy for aging people. Utilizing a cost-effective 
analysis, the relationship between various healthcare expenditures and conditional life 
expectancy for people aged 60 and above was examined. A linear regression model was used 
to analyze data from 122 WHO (World Health Organization) countries obtained from the 
year 2000. The model included additional health-adjusted life years (HALE) at age 60 as the 
dependent variable and healthcare cost indicators as the independent variables. Regression 
results revealed that cost of healthcare was overall significant in contributing to HALE at age 
60. The independent cost variables that were individually significant in the model consisted 
of government expenditure, private healthcare expenditure, out-of-pocket expenditure, and 
social security funding. While public healthcare costs such as government expenditure and 
social security funding positively impacted HALE, private healthcare expenditure negatively 
impacted HALE years at age 60. This finding suggests that countries with higher private 
healthcare expenditure than public healthcare expenditure decreased their chances of 
improving life expectancy for senior citizens. Through a cost-effective lens, in order to 
increase the quality and quantity of healthy life years for the elderly, countries should focus 
on instating policies that fund more public healthcare services.  
 
 
INTRODUCTION 
 
Healthcare is amongst the most pressing issues regarding the economy and public 
welfare today. The World Economic Forum ranks healthcare in their top ten biggest global 
challenges of 2016 stating that the number of people in the world is set to rise to 9.7 billion 
people by 2050 and countries need to begin adjusting their healthcare systems for this 
immediately.1 On top of that, recent spreads of deadly diseases such as HIV (human 
immunodeficiency virus) /AIDS (acquired immune deficiency syndrome) and Ebola in 
mainly developing countries have made the initiative to improve healthcare services even 
more crucial.  
																																																						
1 Rosamond Hutt, "What Are the 10 Biggest Global Challenges?," World Economic Forum, last 
modified January 21, 2016, https://www.weforum.org/agenda/2016/01/what-are-the-10-biggest-
global-challenges/. 
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The reason why health epidemics still pose as a great threat is because people around 
the world still don’t have access to immediate or basic health services. Even today in a 
developed country like the United States, that spends the most money on public health care 
compared to other countries, 27 million US citizens still live uninsured.2 Recently, countries 
have been implementing policies on healthcare that aim to ameliorate the use of government 
healthcare budgets, the coverage of more health services, and the accessibility of healthcare 
insurance. For example, in 2008, the government of Ghana instated a mandatory “free 
maternal healthcare” policy, which strived to facilitate access to free and quality maternal 
healthcare services such as antenatal, delivery, and postnatal care.3 In essence, it has become 
important goal for nations around the world to recognize successful health systems that can 
reach out to more people and offer useful services that improve the quality of health.  
As mentioned earlier, the world is on the brink of a major population growth. Of that 
population growth, the age group scientists expect to see rapidly increase in the years to 
come consist of older aged people. Researchers at the World Health Organization (WHO) 
predict that the number of people aged 65 or older will begin to outnumber children aged 5 
and below.4 Driven by falling fertility rates and remarkable increases in life expectancy, 
populations 65 and older will grow from an estimated 524 million in 2010 to nearly 1.5 
																																																						
2 Garfield, Rachel and Anthony Damico. “The Coverage Gap: Uninsured Poor Adults in States That 
Do Not Expand Medicaid.” The Henry J. Kaiser Family Foundation. Jan. 21, 
2016. http://kff.org/health-reform/issue-brief/the-coverage-gap-uninsured-poor-adults-in-states-that-
do-not-expand-medicaid-an-update/ 
 
3 Ghana Business News, "Ghana’s Free Maternal Healthcare Policy Not Working – Research," 
Ghana Business News, last modified April 23, 2016, 
https://www.ghanabusinessnews.com/2016/04/23/ghanas-free-maternal-healthcare-policy-not-
working-research/. 
 
4	Global Health and Aging (World Health Organization, 2011),  
http://www.who.int/ageing/publications/global_health.pdf. 
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billion in 2050, with most of the increase in developing countries. Furthermore, the WHO 
anticipates the aging population to also become more racially and ethnically diverse, which 
will present challenges to policy makers in programs such as social security and public 
healthcare.5  
With a diverse older population soon to be the majority, it is now even more 
necessary to ensure that their health and safety are in good condition. Additionally, it is 
important to take care of older people from an economical standpoint. Currently, a new trend 
of older people postponing their retirement and working longer has begun to develop in many 
countries, resulting in increased labor productivity in markets.6 Another trend that has 
persisted in the economy is older citizens up to the age of 75 are becoming the breadwinners 
in families for childcare, financial assistance, and tax payments.7 From a more social 
standpoint, it is recognized how elders in society have had the most life experience in 
understanding worldly affairs such as relational, political, and cultural change. They then 
pass down their expertise and knowledge to future generations in an effort to maintain the 
heritage and cultural values of their respective communities in countries all over the world.8 
Therefore, bettering healthcare to increase life expectancies for older populations is not only 
a basic human right, but also a beneficial tool in improving many social and economic 
aspects of countries. Keeping this in mind, I will attempt to construct a study that focuses on 
																																																						
5 Global Health and Aging (World Health Organization, 2011), 
http://www.who.int/ageing/publications/global_health.pdf. 
	
6 "Ageing Societies: The Benefits, and the Costs, of Living Longer," International Labour 
Organization, last modified December 1, 2009, http://www.ilo.org/global/publications/world-of-work-
magazine/articles/WCM_041965/lang--en/index.htm. 
 
7 Judith Healy, "The Benefits of an Ageing Population," Australian National University, last modified 
March 2004, http://www.tai.org.au/documents/dp_fulltext/DP63.pdf. 
	
8 Judith Healy, "The Benefits of an Ageing Population," Australian National University, last modified 
March 2004, http://www.tai.org.au/documents/dp_fulltext/DP63.pdf.	
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which types of healthcare services provide better health outcomes for this population. The 
specific research question I will examine is: which different healthcare cost indicators affect 
the conditional life expectancy (or the life expectancy assuming survival regardless of 
disease/illness conditions) for older populations aged 60 and above around the world?  
In this study, I intend to first begin by providing a descriptive overview of the 
previous studies that make use of existing approaches, which analyze the relationship 
between cost and healthcare as well as the relationship between the elderly and health 
outcomes. Afterwards, I will develop an empirical model that is appropriate in answering the 
research question and will also test the proposed economic theory about quality versus 
quantity of added years of life expectancy for older populations over 60. The empirical 
model will consist of a regression that examines the effect of multiple types of healthcare 
expenditures on health-adjusted life years, or HALE, at age 60. A cost-effective approach 
will then be used to analyze the results of cost on conditional life expectancy in terms of 
quantity and quality of health for older populations.  
 
LITERATURE REVIEW 
 
What does a cost-effective analysis of a healthcare system look like? 
 While major health organizations such as the OECD and the WHO have been ranking 
healthcare systems around the world with indicators based on quality, cost, efficiency, and 
health outcomes, recent studies in health have developed a new tool to analyze healthcare 
systems with cost effectiveness. By definition, a “cost-effective analysis” is a method for 
assessing gains in health relative to the costs of different health interventions (Jamison 2006). 
A “cost-effective” analysis on healthcare compares the quality of health outcomes in relation 
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to cost. Based on this, a cost effective analysis can also determine whether or not healthcare 
systems are “efficient,” or more specifically if certain healthcare systems produce better 
quality health outcomes with low costs compared to others. Even this is hard to identify, as 
there are many theoretical questions that lie in cost-effective analyses such as, what is gain in 
healthcare? How do we measure it? What is quality of healthcare? What are the different 
costs of health interventions? I will attempt to explore the different ways through which 
economists have approached cost-effective analyses in healthcare.  
Cost-effective incentives in healthcare systems can be first understood through the 
relationship between cost and quality. In a study measuring the Dutch healthcare system’s 
performance in patients with diabetes, multi-dimensional quality and cost indicators were 
used to test whether or not the patients could get the same quality care with lower and higher 
costs. Researchers used a combined cost-consequence analysis (CCA) to gain more insight 
on the Dutch healthcare system’s performance. A cost‐consequence analysis is a type of 
health economic evaluation in which all direct and indirect costs of healthcare are listed 
separately from each other and then are compared to different health outcomes. Results from 
this study indicated that predicated quality of diabetes care was achieved with lower instead 
of higher costs (Portrait, Galien, and Berg 2015). Therefore, it can be seen how getting 
similar quality healthcare with lower costs is the first approach economists go about 
addressing cost-effectiveness – by talking about cost efficiency and quality.  
Another approach that uses cost effective analysis to examine the relationship of 
efficiency and cost in healthcare was conducted economist Michael D. Rosko in 2001. Rosko 
(2001) in his study uses a stochastic frontier model to estimate inefficiency scores in 1,631 
US hospitals during the period 1990 – 1996. Stochastic frontier regression (SFR) is an 
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econometric technique which accounts for random shocks or error in periods of time when 
estimating the efficiency at the observed level of outputs and inputs. The results of from this 
study suggested that US hospitals’ inefficiency scores were negatively associated with health 
medical organization (HMO) penetration, or the proportion of HMO enrolment per county 
(Rosko 2001). In other words, there was an inverse relationship between HMO penetration 
and inefficiency, indicating that the growth of managed care actually decreased the hospital 
efficiency levels.  
Cost-effective analyses so far have broadly been used to measure relationships 
between cost, quality, and efficiency in health care. However, cost-effective analyses also 
can be used to reveal hidden or overlooked costs, termed as “unrelated costs,” and how they 
affect healthcare systems. In a study titled “Future Costs, Fixed Healthcare Budgets, and the 
Decision Rules of Cost-Effectiveness Analysis,” Van Baal, Meltzer, and Brouwer (2014) 
examine the unseen costs of life-saving medical technologies and medical interventions 
administered to cancer patients. Because these technologies and services are mainly used for 
treatment to side effects of cancer, they do not get counted in overall future costs of cancer 
treatment. Therefore, this study questions whether or not it is beneficial to include future 
costs of both related and unrelated medical care costs in economic evaluations of a healthcare 
system’s performance. Through a theoretical lens, these economists suggest that both the 
costs and benefits of unrelated as well as related medical care together is a cost-effective 
approach that health insurers need to take. They believe this because with a picture of all the 
costs that are used towards health treatments, policy makers receive a more informative take 
on how to make a more efficient use of their designated healthcare budget (Van Baal, 
Meltzer, and Brouwer 2014).    
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How does cost-effective analyses affect overall health outcomes? 
One of the most renown and oldest paradigms for analyzing the quality of healthcare, 
the Donabedian model, deals with evaluating the medical care process at the level of 
physician-patient interaction. In this model, Donabedian (1966) discusses how there are three 
key approaches that can be used to analyze the quality of a healthcare system – process, 
structure, and outcome. Focusing specifically on the outcome approach, the Donabedian 
model suggests how outcomes of medical care have been frequently used as measurable 
indicator for quality because they have “end points” or concrete factual data that are 
quantifiable (Donabedian 1966). However, this approach also mentions how even though 
outcome measurements are quantifiable in measuring quality, they can also be irrelevant 
without a chosen criterion. In this case, that criterion is cost effectiveness, as this study will 
question whether or not multiple cost indicators are effective in contributing to health 
outcomes for the elderly.  
 The following literature demonstrates how a cost-effective analysis can be performed 
using Donabedian’s outcome approach to measure quality of healthcare. Examining the 1985 
Medicare Provider Analysis File (MEDPAR), author Steven T. Fleming uses cost-effective 
analysis to measure US hospital quality in terms of outcomes such as risk-adjusted mortality 
and readmission indices. Risk-adjusted mortality rates are mortality rates from the RAMI 
(Risk-Adjusted Mortality Index) that are adjusted for predicted risk of death. Readmission 
indices for this study measure the number of scheduled and unscheduled readmission of 
patients from the RARI (Risk-Adjusted Readmission Index) that occur 31 days following a 
patient’s discharge. Fleming (1991) discovered in his work that the behavior of hospitals in 
response to cost constraints and behavioral consequences on medical outcomes, depended on 
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where they were put on a cubic cost function in terms of quality measured by the Medicare 
Provider and Analysis Review (MedPAR) (Fleming 1991). The analysis of the results found 
that when the level of quality in hospitals was low, a cost reduction was associated with 
poorer health outcomes and vice versa (Fleming 1991).  
Another study conducted some years later on 137 Department of Veteran Affairs 
hospitals from 1988-1993, used Fleming’s work to conduct a similar cost-effective analysis. 
Using Fleming’s cubic cost function that accounted for the risk-adjusted measures of 
mortality and readmission, researchers Carey and Burgess (1999) also found in their study 
that in veteran hospitals, cost and health outcomes were positively related. However, they 
also recognized that Fleming’s cubic cost function was inaccurate because it failed to account 
for factors which could have affected mortality and readmission rates such as severity of 
illnesses (Carey and Burgess 1999). Therefore, Carey and Burgess conclude that further 
research must be done to not only improve upon the cubic cost function, but also 
simultaneously accurately adjust for severity of patients’ illnesses in a model that utilizes 
mortality and readmission rates.  
What does better health outcomes for the elderly consist of? 
 We have talked about what cost-effective analyses healthcare consist of and how they 
affect health outcomes. However, these studies have pertained to general patient and hospital 
data without any specific focus on age, gender, or race (which previous literature has 
controlled for). For this paper, I attempt to focus on the older age category of patients. Hence, 
it is necessary to recognize previous studies conducted on this population regarding which 
health outcomes, apart from life expectancy, have been used to measure cost effectiveness in 
healthcare.  
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 One article titled Health Insurance, Medical Care, and Health Outcomes: A Model of 
Elderly Health Dynamics, utilizes prescription drug coverage, measured as a percent of 
Medicare coverage dedicated to paying for prescribed drugs, as a measurable health outcome 
of the US’s elderly population (Yang, Gilleskie, and Norton 2007). This study examined the 
effect of Medicare prescription drug coverage on the overall rate of expenditure on medicine 
for older populations. Results revealed that prescribed drug coverage increased the overall 
drug rate by 7% to 25% over a five-year period and decreased mortality rates for the elderly 
as well. Another article accounts for time as a cost factor used to determine health outcomes 
for the elderly. This study aimed to explore the effect of the cost of time on physical exercise, 
which measured the health-related quality of life for seniors. With data from a 4-year 
randomized controlled trial, Eastern Finnish men and women aged 57-78 were surveyed with 
a questionnaire regarding the cost and time they put into physical exercise. The outcome of 
this survey illustrated that motivation and the labor market position are important factors in 
determining the cost of physical exercise in terms of time. Furthermore, an increase in time 
spent on physical exercise for senior citizens had positive effects on their health outcomes 
such as it improved physical and mental components of health (Kollner, Valtonen, 
Komulainen, Hassinen, and Rauramaa 2012).  
Another study, which looks at the impact of health insurance public policy called 
China’s New Cooperative Medical Scheme (NCMS) for senior citizens, used three different 
types of health outcome measures – mortality within three years, self-reported health (or 
survey-reported health), and measured health through hospital physical examinations. 
Launched in 2003, the NCMS is a public healthcare insurance system instated in rural areas 
of China. This study attempts to assess the effect of NCMS on specifically senior citizens in 
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rural areas of China. Results of this study revealed that rural senior citizens classified as low-
income benefitted more than rural senior citizens classified as high-income (Cheng, Liu, 
Zhang, Shen, and Zeng 2014).  Additionally, this study reports that in rural counties in China, 
NCMS had no significant effect on healthcare-uninsured seniors in terms of mortality rates, 
but did moderately reduce the mortality rates for healthcare-insured seniors (Cheng, Liu, 
Zhang, Shen, and Zeng 2014).  
There are a plethora of studies that have tried to answer the question of what 
constitutes better health outcomes for older populations across the globe apart from ones 
cited. With this paper, my goal is to contribute a different cost-effective approach in 
determining the quality of health outcomes for the elderly. The “different” cost-effective 
approach I use specifically examines the quality of conditional life expectancy for older 
populations. This approach will include the types of healthcare costs that affect the 
conditional life expectancy of the elderly and whether or not they improve the quality of 
health per year as well.   
 
THEORY & MODEL 
 
 
Using a classical linear regression model, I will attempt to test the economic theory of 
“quality versus quantity” and analyze it in terms of life expectancy for senior populations. 
The “quality versus quantity” economic theory was developed in an article called Interaction 
between Quantity and Quality of Children by economists Gary S. Becker and Gregg Lewis at 
the University of Chicago back in 1974. Becker and Lewis (1974) argued that the 
relationship between quantity of children per household and quality of children per 
household was closely related. For the purposes of this study, “quality” of children can be 
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defined as the rate of consumption for each child and “quantity” of children can be defined as 
the number of children per household. More importantly, Becker and Lewis (1974) used 
“shadow prices,” or estimates of the cost of one child per household with respect to 
household income level. They concluded that theoretically quality affected the price of 
children more than the quantity, as households with higher income levels with less children 
cost more to take care of than lower-income households with more children (Becker and 
Lewis 1974). Higher-income households have higher-quality children that consumed more 
than lower-quality children from lower-income households, hence why children of higher-
income households had higher prices.   
 I attempt to investigate if Becker and Lewis’s findings are consistent with the 
empirical cost-effective model on healthcare being tested in this paper. I will see whether or 
not a close relationship between quantity and quality of life expectancy for older populations 
exists as it does for children. More specifically, this model will investigate which cost 
indicators of healthcare affect the quality of health added to the lives of the elderly.  
 In the linear multi-regression model, the dependent variable, or Yi, will be HALE at 
age 60 (measured as a number of additional years to age 60). The cost indicators that will be 
chosen as the explanatory, independent variables for this regression include: external 
resources on health, general government health expenditure, out-of-pocket expenditure, 
private health expenditure, private insurance, social security funds, total health expenditure 
(THE), total health expenditure per capita (THE per capita), and developed or developing 
nation as a dummy variable (where developed nations =1 and developing nations =0).  
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Hence, the regression model is generally identified as: 
Yi = β0 + β1 Xi1 +…+ βp Xip + εi  
where Yi is the dependent variable, Xip is the number of independent variables, βs are the 
coefficients for each independent variable, and εi is the error term (which is equal to 0). 
When we input health life expectancy at age 60 as Yi, or the dependent variable, and all the 
other variables as independent X-variables, the regression equation becomes: 
HALE = β0 + β1 EXT.RES + β2 GGE+ β3 PVT.H + β4 OOP + β5 PVT.I + β6 SSF + β7 THE +  
β8 THE P.C. + β9 DEV.NAT  
In this regression equation, the abbreviations for each variable are:  
HALE = health life expectancy at age 60 (measured as number of additional years to age 60) 
EXT.RES = external resources (measured as a % of total healthcare expenditure)  
GGE = general government expenditure (measured as a % of total healthcare expenditure) 
OOP = out-of-pocket expenditure (measured in US$ per capita) 
PVT.H = private healthcare expenditure (measured as a % of total healthcare expenditure) 
PVT.I = private insurance expenditure (measured % of private healthcare expenditure) 
SSF = social security funding (measured as a percent of general government expenditure) 
THE = total healthcare expenditure (measured as a % of gross domestic product or GDP) 
THE P.C. = total healthcare expenditure per capita (measured in US$ per capita) 
DEV.NAT = developed/developing nation (measured as two possible outcomes, 1 and 0) 
Each variable in this equation has an in depth description and explanation to why it 
has been included in the model that can be seen in Appendix A at the end of this study.  Also, 
Appendix A includes more information on the unit of measure for each independent variable 
in the model.  
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DATA 
  
Most of the data (with the exception of the variable DEV.NAT) for the regression 
model has been obtained from the World Health Organization (WHO) database. Established 
in 1948, the WHO is a specialized agency of the United Nations concerned with international 
public health policies.  Furthermore, the WHO uses its Global Health Observatory data to 
serve as a gateway to health-related statistics for more than 1000 indicators for 194 member-
countries around the world. For the purposes of the regression model stated previously, the 
data obtained was mostly cross-sectional specifically for year 2000. Cross sectional data can 
be recognized as a type of data collected by observing many subjects (such as individuals, 
firms, countries, or regions) in one specific time period. 
However, due to an unexpectedly large amount of missing data for particular 
countries, two of the countries’ data (Afghanistan and Cote d’Ivoire) have been taken from 
2002, making the entire model technically pooled cross-sectional data, or data that has 
randomly sampled observations of subjects at different time periods. Because this model has 
HALE at age 60 as the dependent variable, the only year in the WHO database that contained 
this information was 2000. Furthermore, even though there are 194 member countries, only 
122 out of those 194 countries contained data for all of the healthcare cost indicators. 
Therefore, because this model uses the number of countries as the number of observations, 
the total number of observations for this regression model was equivalent to 122. Reasons for 
the missing 72 member-countries’ data include blanks for some of the independent variables. 
The WHO records blanks in the data under the following conditions: no applicability, 
financial constraints, lack of resources, or no registration of the unit. The data for the dummy 
variable, developed/developing nation (DEV. NAT), has been obtained from the 
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Development Policy and Analysis Division (DPAD) of the Department of Economic and 
Social Affairs in the United Nations Secretariat. The United Nations Secretariat is one of the 
six major branches of the United Nations (UN). The UN is the largest and most familiar 
intergovernmental organization that promotes international cooperation and maintains 
international order amongst 193 member-countries.9 The summary statistics of each variable 
in the regression model can be seen below in Figure 1.  
 
Figure 1: This table displays the summary statistics for each variable (dependent and independent) in the 
regression model described in the previous section. Units of measurement for each variable are in parenthesis 
next to the abbreviations. DEV.NAT has no units of measure next to it since it is a dummy variable with only 
two possible outcomes. Note: Please refer to Appendix A for more information on units of measure.  
 
Figure 1 reveals that the range of the dependent variable, HALE, is quite short from 
7.5 – 18.2 years, implying that there is only 10.2 years of variation amongst all 122 countries. 
Also, it can be seen how some of the minimum values for quantitative variables such as 
EXT.RES, PVT.H, and SSF are “0.” This signifies that some countries do not have this type 
																																																						
9 National Geographic, "International Organization," National Geographic, 
https://www.nationalgeographic.org/encyclopedia/international-organization/. 
Variable Observations Mean Standard 
Deviation 
Minimum Maximum 
HALE (# years) 122 13.50164 2.273425 7.5 18.2 
EXT.RES (%) 122 7.172755 10.65738 0 71.11573 
GGE (%) 122 53.87585 20.39795 7.094141 94.27777 
OOP (US$ per capita) 122 87.22806 150.3502 1.561323 1167.61 
PVT.H (%) 122 46.31678 20.49953 5.722225 96.90898 
PVT.I (%) 122 10.16374 14.66201 0 77.27142 
SSF (%) 122 21.60984 32.08491 0 99.00284 
THE (%) 122 5.712966 2.124009 1.836784 13.63 
THE P.C.  
(US$ per capita) 
122 416.9336 794.0728 3.194748 4788.312 
DEV. NAT  122 0.172131 0.3790511 0 1 
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of cost indicator implemented or do not have a policy that include these types of funding. For 
example, 51 countries out of the 122 did not have a recognized social security funds program 
for senior citizens. Therefore, the WHO records these values as 0% of general government 
expenditure (does the same for the other cost indicators in the model represented in 
percentages too). Also note that the minimum and maximum values of the DEV.NAT 
variable is 0 and 1 respectively because it is a dummy variable.  
Before analyzing the data, another important aspect to test for is if the independent 
variables in the regression model are collinear with each other or not. When independent 
variables are collinear to each other in a model, it makes one independent variable’s data 
dependent on another independent variable. In order to use a linear regression, estimators in 
the model must be independent of one another so that the error in each variable is random 
and minimized. With high or perfect multicollinearity between variables, this assumption is 
violated. Highly correlated variables have many potential consequences in a regression 
model such as producing misleading hypothesis testing results, giving insignificant 
coefficient signs or magnitudes, and generating larger standard errors for each variable. 
Therefore, the collinearity between variables have been outlined in Figure 2 and Figure 3, 
which look at the correlation coefficients and variance inflation factors (VIF) respectively. 
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Figure 2: This table displays a correlation coefficient matrix for variables (dependent and independent) in 
pairs. The correlation coefficients, or r-values, in the table are meant to represent the collinearity between the 
variable on the first row with each other variable on the first column. For example, the r-value between 
variables HALE and EXT.RES in the first column is -0.496. Note that the r-value will be 1.000 if the variable 
on the horizontal row is being paired with itself on the column. R-values that are higher than .8 indicate high 
collinearity between two variables. Note: Please refer to Theory & Model section for variable abbreviations. 
 
 
 
 
 
 
 
 
 
Figure 3: This table displays the variation inflation factor (VIF) calculations for variables (dependent and 
independent) in the regression from the previous section. VIF statistics represent each variable’s collinearity to 
the regression model overall. Represented in descending order from highest to lowest in value, VIF calculations 
greater than 10 signal a variable has high collinearity in the regression model. The same applies for the mean 
VIF of the model, as it must be below 10 in order to have no high multicollinearity. Note: Please refer to 
Theory & Model section for variable abbreviations.  
 
 HALE EXT. 
RES 
GGE OOP PVT. 
H 
PVT. 
I 
SSF THE THE 
P.C. 
DEV. 
NAT  
HALE  1.000          
EXT. 
RES 
-0.496 1.000         
GGE 0.442 -0.095 1.000        
OOP 0.583 -0.303 0.180 1.000       
PVT. H -0.426 0.088 -
0.994 
-
0.175 
1.000      
PVT. I 0.366 -0.289 0.151 0.324 -0.135 1.000     
SSF 0.472 -0.289 0.215 0.302 -0.216 0.207 1.000    
THE 0.375 -0.154 0.140 0.525 -0.136 0.305 0.425 1.000   
THE 
P.C. 
0.609 -0.282 0.313 0.087   -0.312 0.420 0.562 0.360 1.000  
DEV. 
NAT 
0.587 -0.288 0.402 0.654 -0.404 0.210 0.403 0.462 0.757 1.000 
Variable VIF 
PVT.H 97.25 
GGE 96.74 
THE P.C. 7.10 
OOP 4.81 
DEV. NAT 2.81 
THE 1.65 
PVT.I 1.41 
SSF 1.38 
EXT. RES 1.24 
Mean VIF 23.82 
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In Figure 2, we see alarmingly large correlation coefficient shared between general 
government expenditure (GGE) and private healthcare expenditure (PVT.H) of -0.994, which 
indicates both are highly collinear to each other. In Figure 3, we see the VIF statistics for 
both to be high as GGE is 96.74 and PVT.H is 97.25, signifying that there is high 
multicollinearity in the regression model overall. Referring to the definition of total 
healthcare expenditure (THE),10 it can be seen why this is the case. Both GGE and PVT.H 
are the two major components that make the sum of THE and therefore the values for each 
can be predicted if the other is present. All the other paired variables maintain relatively low  
r-values and VIF statistics, therefore passing as not collinear to each other and to the 
regression model overall.  
To address the highly collinearity of GGE and PVT.H, I divided the model into two 
separate regressions which has one of the two variables defined as: 
 
MODEL 1 (GGE included): HALE = β0 + β1 EXT. RES + β2 GGE + β3 OOP + β4 PVT.I +  
β5 SSF + β6 THE + β7 THE P.C. + β8 DEV. NAT 
 
MODEL 2 (PVT. H included): HALE = β0 + β1 EXT. RES + β2 PVT.H + β3 OOP + 
β4 PVT.I + β5 SSF + β6 THE + β7 THE P.C. + β8 DEV. NAT 
 
 
 
 
																																																						
10 Refer to Appendix A  
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RESULTS 
 
HALE (# of years) MODEL 1 MODEL 2 
EXT. RES (%) -0.0552*** (0.01358) 
-0.0553*** 
(0.01368) 
GGE (%) 0.0288*** (0.00732) - 
OOP  
(US$ per capita) 
0.0042** 
(0.00187) 
0.0043** 
(0.00189) 
Pvt. H (%) - -0.0271*** (0.00735) 
Pvt. I (%) 0.0141 (0.01039) 
0.0149 
(0.01046) 
SSF (%) 0.01481*** (0.00539) 
0.01483*** 
(0.00543) 
THE (%) -0.0285 (0.07606) 
-0.02909 
(0.07665) 
THE P.C.  
(US$ per capita) 
0.0003 
(0.00042) 
0.00002 
(0.00043) 
DEV. NAT  0.7469 (0.59570) 
0.7786 
(0.60035) 
CONS  11.5269*** (0.56706) 
14.3299*** 
(0.54076) 
  
 
MODEL 1             
N = 122 
R2 = 0.6101 
F = 22.10*** 
MODEL 2 
N = 122 
R2 = 0.6042 
F = 21.57*** 
Figure 4: This table displays the regression results for Model 1 and Model 2 holding HALE as the dependent 
for both. A new abbreviation, CONS, is introduced here as it stands for the constant in the model. Coefficients 
for each independent variable are on the first line of each row and its standard errors are right below in 
parenthesis on the second line of each row. In Model 1, PVT.H has a dash because it was omitted; and for 
Model 2, GGE has a dash because it was omitted. Significance of the coefficients are indicated under the 10% 
level (*), under the 5% level (**), under the 1% level (***).  This regression already accounts for 
multicollinearity and heteroskedascticity (none were present in the model). Note: Please refer to Theory & 
Model section for variable abbreviations and Appendix A for more information on units of measure.  
 
 
From the results in Figure 4, which include Model 1 and Model 2, both have an R2 
value that allows us to explain about 60% of the variation in the data. Furthermore, along 
with a high R2 value, the F-statistic of both Model 1 and Model 2 are significant as well 
under the 1% level, indicating that the results of each model hold overall significance. Of the 
individual variables, the statistically significant variable under the 5% level was out of pocket 
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expenditure; and under the 1% level were EXT.RES, GGE (in Model 1), PVT.H (in Model 
2), SSF, and CONS. The insignificant variables remained the same across both Model 1 and 
Model 2, as they were PVT.I, THE, THE P.C., and DEV.NAT.  
Focusing specifically on Model 1, which included government general expenditure 
(GGE) instead of private healthcare (PVT.H), the first statistically significant variable is the 
constant (CONS). The coefficient of the constant being statistically significant indicates that 
the minimum amount of HALE years for people at age 60 is approximately 11, which is 
relatively high. The reason why it can be deemed as high is because if we were to look at 
Figure 1, the mean of HALE was about 13 across all countries and the coefficient of the 
constant itself is about 11 years. This implies that without any funding or expenditure, 
seniors will still be given a minimum of 11 years to live after 60 reaching a life expectancy of 
71 years, which is only about 2 years less than the average (73 years). The second significant 
variable is social security funding with a positive coefficient of 0.0148, which means that for 
every 1% social security funding went up, HALE increased by about 0.0148 of a year. In 
reality, this is a relatively small magnitude because mathematically even if we were to 
increase social security funding by 100%, life expectancy would only increase by 1.5 years 
or about 1 year and 6 months for people at age 60. Similar results were drawn even when 
looking at the third positive significant variable in Model 1, general government spending 
(GGE). In spite being significant, if general government spending were to increase also by 
100%, its coefficient suggests that HALE would only increase by 2.9 years or about 2 years 
and 10 months. The fourth positive statistically significant variable in Model 1, which had 
the greatest impact on HALE with a coefficient of 0.0042, conveys how for every $100 spent 
out of pocket on healthcare, HALE at age 60 increased by .42 years or almost 5 months.   
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The fifth statistically significant variable in Model 1, which also had the greatest magnitude, 
was extra resources (EXT.RES) and it was negative. The coefficient on EXT.RES in Model 1 
suggests that for every 1% increase in external resources, HALE years decreased by 0.0552 
years. Again to provide a clearer picture of this coefficient’s magnitude, mathematically if 
we were to increase external resources by 100%, then the life expectancy for people 60 and 
above would decrease by more than 5 and half years.  
 In the results of Model 2 in Figure 4, which included private healthcare expenditure 
(PVT.H) as opposed to general government expenditure (GGE), once again the constant 
(CONS) was statistically significant. Except this time, CONS in Model 2 exhibited a higher 
coefficient of 14.322 than CONS in Model 1. Again, this implies that the minimum amount 
of HALE years at age 60 that will be added without any healthcare cost is about 14 years, 
giving a life expectancy of about 74 years, which is even greater than the average life 
expectancy too. Observing the other statistically significant coefficients in Model 2, we see a 
minuscule difference in magnitude for EXT. RES, SSF, and OOP. Therefore, the main result 
Model 2 mainly offers is PVT.H being significant with a negative coefficient of .029599. 
This signifies that a 100% increase in private healthcare expenditure would result in a 
decrease in life expectancy at age 60 of approximately 3 years. The fact that PVT.H had a 
negative coefficient is interesting, since this insinuates that the variable had an adverse effect 
compared to GGE on HALE.  
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CONCLUSION 
 
With an R-squared of about 60% in both Model 1 and Model 2, overall it can be 
stated that cost is a significant contributor in determining the conditional life expectancy for 
older populations 60 and above. Furthermore, how different countries choose to fund certain 
programs or resources does affect the quality of elderly healthcare, hence ultimately 
determining how long more they can live. Both models showed that external resources 
expenditure, general government expenditure, private healthcare expenditure, social security 
funds, and out-of-pocket expenditure affected the conditional life expectancy for the elderly.  
 The first important point to be drawn from the results is that even though general 
government expenditure was significant in Model 1 and private healthcare expenditure was 
significant in Model 2, both variables had opposite effects on conditional life expectancy. 
The negative coefficient of private healthcare expenditure in Model 2 suggests that countries 
with higher percentages of private healthcare spending lowered the number of HALE years 
for the elderly. It also implies that countries with more public healthcare costs exhibited 
higher HALE year rates than countries with more private healthcare costs. Therefore, 
countries that had more private healthcare coverage than public deteriorated their potential to 
increase life expectancy for senior citizens. Essentially, this model contradicts the norm that 
private healthcare coverage is “better” in terms of service, healthcare, and quality – at least 
for older populations. Although out-of-pocket expenditure did help with HALE years in 
Model 1, it can be argued that it was offset by the negative coefficient of private healthcare 
expenditure in Model 2. Therefore, it can be interpreted that seniors 60 and over who spend 
more out of their pocket on various health services are helping to increase their life 
expectancy if they have government-funded healthcare as opposed to private healthcare.    
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 However, the most eye-catching significant variable in this study, which had the 
largest adverse effect on conditional life expectancy, was external resources. One would 
think that extra resources for funding outside of private and public healthcare would 
positively impact life expectancy for the elderly rather than deteriorate it. Although this result 
may seem confusing, it can be explained by the following theory. The demographic of the 
countries that were chosen in the dataset was back in 2000, or 17 years ago. Developing 
nations at that time such as Guinea, Comoros, Cambodia, and more had higher values for 
external resource funding because they were relatively new sovereign states looking to lean 
on outside countries for foreign aid. These same developing nations have comparatively 
lower HALE expectancy years for the elderly than developed nations because they were so 
new nations in 2000 and had not yet grown. Therefore, external resources was represented as 
a negative coefficient since the foreign aid and extra funding for these developing countries 
had still not taken affect. If the cross-sectional data for HALE years at age 60 was taken from 
a more recent year such as 2015, the results for extra resources as a healthcare cost indicator 
might have been different. Consequently, extra resources as a variable has the potential to 
improve life expectancy for senior citizens despite having a negative coefficient in this 
model, but we would have to test it for a more recent year to see.  
 From a cost analysis standpoint, it is established that public healthcare expenditure 
helps to better conditional life expectancy for the elderly over private healthcare expenditure. 
Furthermore, this model helps to not only reveal which particular healthcare costs are 
significant in increasing life expectancy, but also in increasing the quality of life for older 
populations. The term, “health-adjusted life years,” or “HALE,” The World Organization has 
defined to be the number of additional years a certain person can live in “full heath” without 
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disease or injury on average.11 Essentially, HALE becomes a qualitative indicator along with 
a quantitative indicator for life expectancy for people aged 60 and above. Through HALE’s 
definition, it can be assumed that there is a proportional relationship between quality and 
quantity of life expectancy – the more HALE years people gain, the better quality health they 
get per year.  
Alluding to Becker and Lewis’s quality versus quantity theory, the findings from this 
study are consistent with their prediction of quality and quantity having a close relationship.  
In countries that had higher HALE years because of higher public healthcare costs, the 
quality of health for people over 60 increased as well since they got to live longer in full 
health. It can be further argued that the reason why general government expenditure and 
social security seemed to be more beneficial in terms of HALE than private healthcare 
expenditure is because its health services are targeted more towards increasing the quality of 
health. For instance, countries with social security programs (i.e. United States, Canada) give 
money to senior citizens who use it not just for healthcare, but also for other factors that 
contribute to a healthy lifestyle such as retirement, social activities, and living in senior home 
communities.  
 While this study helps to explain the effect of cost on elderly life expectancy, there 
were many limitations. Some of the limitations that affected the conclusions drawn in this 
paper included lack of information involving costs directly associated with senior citizen 
healthcare, missing data in the model, and accounting for only one year of data. Future 
research that can be made on this study should include these missing factors and further 
examine more quality measures other than HALE for ageing populations. Moreover, further 
																																																						
11	Refer to Appendix A  
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research should be more specific in associating direct senior citizen healthcare costs with 
senior citizen life expectancy to help strengthen the cost-effective analysis. Future research 
also should provide time series data, or data collected over a longer period of times, so that a 
change in each healthcare cost variable’s effect on life expectancy could be analyzed. With 
time series data, rather than having a linear multi-regression model that does not account for 
time and fixed effects, a panel regression model can be performed to obtain results for each. 
 After assessing the quality and quantity gains in health for older populations, it is 
clear that public healthcare expenditure is necessary in improving both. Hence, public policy 
makers of countries around the world should aim to provide more funding towards public 
healthcare services for senior citizens that include health insurance coverage, social security, 
and drug-prescription coverage. Senior citizens internationally have a basic human right to 
live their life healthy and for as long as they possibly can in whatever country they reside. 
Therefore, countries need to take into consideration the findings of this study to better rectify 
existing policies and monetary budgets in public healthcare coverage for older populations.  
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APPENDIX A 
																																																						
12 The World Health Organization 
 
13 HelpAge NGO, "History," HelpAge India, https://www.helpageindia.org/aboutus/history.html. 
Variables in Regression Model  In-Depth Explanation/Description 
 
 
 
 
 
Y1 = Health-Adjusted Life Years 
(HALE) at Age 60 
 
 
 
 
 
This dependent variable for our model is 
measured by the additional amount of years the 
WHO predicts an individual can live at age 60.  
Specifically, the WHO explains how they 
measure the additional years of life expectancy 
to be the average number of years a person can 
expect to live in full health by taking into 
account years lived in less than full health due 
to disease or injury.12 From the research 
question proposed, the purpose of this variable 
in this model is to highlight the conditional life 
expectancy of the elderly populations in 
healthcare systems around the world. 
 
 
 
 
 
 
 
 
X1 = External Resources on Health 
(EXT.RES) 
This serves as one of the cost indicators in the 
regression model and is measured as a 
percentage value of total health expenditure 
(THE). Considered a core NHA (National 
Health Accounts) indicator, external resources 
are defined to be funding for healthcare that 
does not come directly from private or public 
financing agents, but through other means. For 
example, funding for public healthcare can 
sometimes come from external private 
insurance agencies or NGO sectors. Many 
sourcing for elderly healthcare activities is 
sponsored from major external resources. For 
example, a huge NGO in India, HelpAge India, 
has spread across 26 states and sponsored right 
from healthcare to home plans for thousands of 
senior citizens.13 
 
 
 
X2 =General Government 
Healthcare Expenditure 
(GGE) 
Another healthcare cost indicator that measures 
the level of general government expenditure on 
health as a percent of total healthcare 
expenditure on health (THE). This variable 
contributes to understanding the relative weight 
of public entities in total expenditure on health.  
It includes resources channeled through 
government budgets to providers of health 
services and the expenditure on health by 
Majumdar  28 
																																																						
14 USA.gov, "Health Insurance Coverage," National Center For Health Satistics, last modified March 
31, 2017, https://www.cdc.gov/nchs/fastats/health-insurance.htm. 
parastatals, extra budgetary entities and health 
insurance payments. For example, in the U.S., 
Medicare or Medicaid covers 26.3% of senior 
citizens over 65 years of age.14 It will be 
interesting to see how much of public 
healthcare covers senior citizen populations 
around the world and how government funding 
for public healthcare affects the outcomes.  
 
 
 
 
X3 = Out-of-Pocket Expenditure 
(OOP) 
As a subset of private healthcare expenditure, 
this cost indicator is expressed as US $ per 
capita. To further clarify, this variable 
measures people’s own payments of private 
pre-paid plans or other risk-pooling plans. Note 
that this variable does not measure coverage of 
private healthcare. Therefore, in terms of cost 
effectiveness, this variable will reveal how 
much money each country’s citizens either 
valuably spend or waste on private healthcare. 
 
 
 
 
 
 
 
 
X4 =Private Health Expenditure 
(PVT.H) 
 
 
 
 
 
 
Expressed as a percent of total health care 
expenditure (THE), this cost indicator the 
WHO defines as the sum of outlays for health 
by private entities. Private entities include 
households, commercial or mutual health 
insurance, non-profit institutions serving 
households, resident corporations and quasi-
corporations with a health services delivery or 
financing function. It includes expenditures 
from all sources, so includes any donor-funding 
passing through these financing agents as well. 
In the U.S., the majority of senior citizens over 
65 are currently covered through private 
insurance with 65%. Therefore, it is important 
to see how many added HALE years these 
citizens will get in the U.S. because the model 
will reveal whether private healthcare better to 
have than public healthcare or not. 
 
 
 
X5 = Private Insurance (PVT.I) 
This cost indicator is expressed as a percentage 
of private healthcare expenditure (PVT.H). To 
further clarify, this variable measures how 
much private insurance companies spend on 
their patients through private pre-paid plans or 
other risk-pooling plans. Note that this variable 
does not measure coverage of private 
healthcare. Therefore, in terms of cost 
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15 The World Health Organization 
effectiveness, this variable will reveal how 
much money each country’s citizens either 
valuably spend or waste on private insurance. 
 
 
 
 
 
 
 
 
 
X6 = Social Security Funds (SSF) 
This cost indicator is expressed as a percent of 
general government expenditure (GGE). The 
WHO defines social security or national health 
insurance schemes to be controlled schemes by 
government units for the purpose of providing 
health services to members of the community. 
They include payments to medical care 
providers and to suppliers of medical goods as 
well as reimbursements to households and the 
direct outlays on supply of services in kind to 
the enrollees. It includes current and capital 
expenditure and donor funds channeled through 
these institutions too.15 Social security is 
probably one of the most prominent ways the 
elderly not only get retirement income, but also 
get direct payment (in checks) from the 
government which they can choose to use 
anyway they want. Hence, it is important to see 
if social security schemes do provide benefits 
to the elderly in terms of health outcomes. 
 
 
 
 
 
 
X7 = Total Health Care 
Expenditure (THE) 
Total healthcare expenditure as a variable is 
measured as a percent of GDP (gross domestic 
product). This independent variable is 
technically comprised of two main branches of 
spending – government and private. Hence, 
total healthcare expenditure is recognized to be 
the sum of all outlays for health maintenance, 
restoration or enhancement paid for in cash or 
supplied in kind and sum of general 
government expenditure and private 
expenditure on health. Not just for seniors, but 
also for all aged citizens, this variable gives a 
macro-economic view of how cost impacts a 
country’s healthcare system provided their 
wealth, demographics, and geography. 
 
 
X8 = Total Health Care 
Expenditure per Capita  
(THE P. C.) 
 
This independent variable measures the same 
premise as the previous x-variable, except it is 
expressed in per capita $US. This variable 
makes it more convenient to compare 
countries’ expenditure against each other using 
a common currency ($US) rather than a 
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16 World Economic Situation and Prospects 2016, report no. 978-92-1-109172-4 (New York, NY: 
United Nations, n.d.), [Page 158], 
http://www.un.org/en/development/desa/policy/wesp/wesp_current/2016wesp_full_en.pdf. 
percentage of GDP (especially considering the 
vast range of GDPs internationally between 
developing and developed nations).  
 
 
 
 
 
 
 
 
 
X9 = Developed/Developing Nation 
(DEV. NAT) 
This independent dummy variable has two 
possible outcomes, 0 = developing nation and 
 1 = developed nation. The United Nations 
categorizes nations around the world to be 
“developed” or “developing” based on their 
gross national income per capita (GNI per 
capita). Countries with less than US$1,045 GNI 
per capita are classified as low-income under 
“developing nations;” those with a GNI per 
capita between US$1,046 and US$4,125 are 
classified as lower-middle income countries 
under “developing nations;” those with a GNI 
per capita between US$4,126 and US$12,735 
were classified as upper-middle income 
countries under “developing nations;” and 
those with a GNI per capita of US$12,735 and 
above are classified as high-income countries 
under “developed nations.”16 This variable is 
meant to see if HALE will be affected by the 
healthcare systems offered in high-income, 
developed countries or lower income, 
developing countries.  
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